PetMed Express Statistics
Total Valuation
PetMed Express has a market cap or net worth of $60.89 million. The enterprise value is $1.92 million.
Important Dates
The last earnings date was Tuesday, October 14, 2025, after market close.
Earnings Date | Oct 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
PetMed Express has 21.00 million shares outstanding. The number of shares has increased by 0.98% in one year.
Current Share Class | 21.00M |
Shares Outstanding | 21.00M |
Shares Change (YoY) | +0.98% |
Shares Change (QoQ) | +0.02% |
Owned by Insiders (%) | 5.54% |
Owned by Institutions (%) | 29.31% |
Float | 14.11M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.24 |
Forward PS | n/a |
PB Ratio | 0.64 |
P/TBV Ratio | 1.10 |
P/FCF Ratio | n/a |
P/OCF Ratio | 11.79 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.01 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.01.
Current Ratio | 1.26 |
Quick Ratio | 0.91 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -6.90% and return on invested capital (ROIC) is -5.62%.
Return on Equity (ROE) | -6.90% |
Return on Assets (ROA) | -3.25% |
Return on Invested Capital (ROIC) | -5.62% |
Return on Capital Employed (ROCE) | -9.65% |
Revenue Per Employee | $790,843 |
Profits Per Employee | -$21,850 |
Employee Count | 287 |
Asset Turnover | 1.42 |
Inventory Turnover | 7.05 |
Taxes
In the past 12 months, PetMed Express has paid $5.68 million in taxes.
Income Tax | 5.68M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.02% in the last 52 weeks. The beta is 0.74, so PetMed Express's price volatility has been lower than the market average.
Beta (5Y) | 0.74 |
52-Week Price Change | -26.02% |
50-Day Moving Average | 2.79 |
200-Day Moving Average | 3.62 |
Relative Strength Index (RSI) | 64.05 |
Average Volume (20 Days) | 112,352 |
Short Selling Information
The latest short interest is 1.79 million, so 8.52% of the outstanding shares have been sold short.
Short Interest | 1.79M |
Short Previous Month | 1.93M |
Short % of Shares Out | 8.52% |
Short % of Float | 12.68% |
Short Ratio (days to cover) | 14.93 |
Income Statement
In the last 12 months, PetMed Express had revenue of $226.97 million and -$6.27 million in losses. Loss per share was -$0.30.
Revenue | 226.97M |
Gross Profit | 69.14M |
Operating Income | -8.29M |
Pretax Income | -587,000 |
Net Income | -6.27M |
EBITDA | -1.25M |
EBIT | -8.29M |
Loss Per Share | -$0.30 |
Full Income Statement Balance Sheet
The company has $54.72 million in cash and $996,000 in debt, giving a net cash position of $53.72 million or $2.56 per share.
Cash & Cash Equivalents | 54.72M |
Total Debt | 996,000 |
Net Cash | 53.72M |
Net Cash Per Share | $2.56 |
Equity (Book Value) | 85.13M |
Book Value Per Share | 4.12 |
Working Capital | 16.10M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $4.72 million and capital expenditures -$5.11 million, giving a free cash flow of -$395,000.
Operating Cash Flow | 4.72M |
Capital Expenditures | -5.11M |
Free Cash Flow | -395,000 |
FCF Per Share | -$0.02 |
Full Cash Flow Statement Margins
Gross margin is 30.46%, with operating and profit margins of -3.65% and -2.76%.
Gross Margin | 30.46% |
Operating Margin | -3.65% |
Pretax Margin | -0.26% |
Profit Margin | -2.76% |
EBITDA Margin | -0.55% |
EBIT Margin | -3.65% |
FCF Margin | n/a |
Dividends & Yields
PetMed Express does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.98% |
Shareholder Yield | -0.98% |
Earnings Yield | -11.27% |
FCF Yield | -0.71% |
Dividend Details Analyst Forecast
The average price target for PetMed Express is $3.20, which is 10.35% higher than the current price. The consensus rating is "Sell".
Price Target | $3.20 |
Price Target Difference | 10.35% |
Analyst Consensus | Sell |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on March 4, 1999. It was a forward split with a ratio of 3:1.
Last Split Date | Mar 4, 1999 |
Split Type | Forward |
Split Ratio | 3:1 |
Scores
PetMed Express has an Altman Z-Score of 2.92 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.92 |
Piotroski F-Score | 2 |